Skip to main content

Publications

Google Scholar site: http://scholar.google.com/citations?user=oABj1aUAAAAJ&hl=en

Research Gate site: https://www.researchgate.net/profile/Benyi_Li

NCBI site: https://www.ncbi.nlm.nih.gov/myncbi/1Hy_tleB5X_ka/bibliography/public/

Publication in recent 5 years:

  1. Liu W, Li JC, Huang J, Chen J, Holzbeierlein J, Li B. Alternol/Alteronol: Potent Anti-cancer Compounds With Multiple Mechanistic Actions. Front Oncol. 2020 Nov 3; 10:568110.
  2. Xu H, Li C, Mozziconacci O, Zhu R, Xu Y, Tang Y, Chen R, Huang Y, Holzbeierlein JM, Schöneich C, Huang J, Li B . Xanthine oxidase-mediated oxidative stress promotes cancer cell-specific apoptosis. Free Radic Biol Med . 2019 Aug 1; 139:70-79. Epub 2019 May 16. PMID: 31103463.
  3. Li C, Sun H, Wei W, Liu Q, Wang Y, Zhang Y, Lian F, Liu F, Li C, Ying K, Huo H, Qi Z, Li B. Mitoxantrone triggers immunogenic prostate cancer cell death via p53-dependent PERK expression. Cell Oncol (Dordr) . 2020 Dec;43(6):1099-1116.
  4. Li C, He C, Xu Y, Xu H, Tang Y, Chavan H, Duan S, Artigues A, Forrest ML, Krishnamurthy P, Han S, Holzbeierlein JM, Li B . Alternol eliminates excessive ATP production by disturbing Krebs cycle in prostate cancer. The Prostate . 2019 May;79(6):628-639. Epub 2019 Jan 20. PMID: 30663084.
  5. Li C, Xu H, Xiao L, Zhu H, Zhang G, Wei W, Li K, Cao X, Shen D, Holzbeierlein J, Li B . CRMP4a suppresses cell motility by sequestering RhoA activity in prostate cancer cells. Cancer Biol Ther . 2018 Aug 6:1-11. doi: 10.1080/15384047.2018.1491507. PMID: 30081723.
  6. He Y, Lu J, Ye Z, Hao S, Wang L, Kohli M, Tindall DJ, Li B , Zhu R, Wang L, Huang H. Androgen receptor splice variants bind to constitutively open chromatin and promote abiraterone-resistant growth of prostate cancer. Nucleic Acids Res . 2018 Jan 4. doi: 10.1093/nar/gkx1306. PMID: 29309643
  7. Yang Y, Bai Y, He Y, Zhao Y, Chen J, Ma L, Pan Y, Hinten M, Zhang J, Karnes RJ, Kohli M, Westendorf JJ, Li B , Zhu R, Huang H, Xu W. PTEN loss promotes intratumoral androgen synthesis and tumor microenvironment remodeling via aberrant activation of RUNX2 in castration-resistant prostate cancer. Clin Cancer Res . 2017 Nov 22. pii: clincanres.2006.2017. doi: 10.1158/1078-0432.CCR-17-2006. PMID: 29167276
  8. Chenchen He, Shaofeng Duan, Liang Dong, Yifen Wang, Qingting Hu, Chunjing Liu, M. Laird Forrest, Jeffrey M. Holzbeierlein, Suxia Han and Li B . Characterization of a novel p110-specific inhibitor BL140 that overcomes MDV3100-resistance in castration-resistant prostate cancer cells. The Prostate . June 2017, 77(11):1187-1198.
  9. Huang S, Li C, Wang W, Li H, Sun Z, Song C, Li B , Duan S, Hu Y. A54 peptide-mediated functionalized gold nanocages for targeted delivery of DOX as a combinational photothermal-chemotherapy for liver cancer. Int J Nanomedicine . 2017 Jul 20; 12:5163-5176. doi: 10.2147/IJN.S131089. eCollection 2017.
  10. Jun Pang, Yue-Wu Yang, Yiling Huang, Jun Yang, Hao Zhang, Ruibao Chen, Liang Dong, Yan Huang, Dongying Wang, Jihong Liu and Li B . P110β inhibition reduces histone H3K4 di-methylation in prostate cancer. The Prostate , Feb;77(3):299-308. doi: 10.1002/pros.23271. Epub 2016 Nov 1. PMID: 27800642
  11. Li B , Li C. Suppression of Prostate Cancer Metastasis by DPYSL3-Targeted saRNA. Adv Exp Med Biol . 2017; 983:207-216. doi: 10.1007/978-981-10-4310-9_15. PMID: 28639202.
  12. Li C, Jiang W, Hu Q, Li LC, Dong L, Chen R, Zhang Y, Tang Y, Thrasher JB, Liu CB, Li B . Enhancing DPYSL3 gene expression via a promoter-targeted small activating RNA approach suppresses cancer cell motility and metastasis. Oncotarget . 2016 Apr 19;7(16):22893-910. doi: 10.18632/oncotarget.8290. [Epub ahead of print] PMID: 27014974
  13. Aijing Sun, Changlin Li, Ruibao Chen, Yiling Huang, Qi Chen, Xiangjun Cui, Huafeng Liu, J. Brantley Thrasher and Li B . GSK-3β controls autophagy by modulating LKB1-AMPK pathway in prostate cancer cells. The Prostate , 2016 Feb; 76(2):172-83. doi: 10.1002/pros.23106. Epub 2015 Oct 6. PMID: 26440826.
  14. Li B , J. Brantley Thrasher and Paul Terranova. Glycogen Synthase Kinase-3: A Potential Preventive Target for Prostate Cancer. Urol Oncol , 2015 Jun 4. pii: S1078-1439(15)00229-X. PMID: 26051358.
  15. Ruibao Chen, Yunqi Zhao, Yan Huang, Qiuhong Yang, Xing Zeng, Wencong Jiang, Jihong Liu, J. Brantley Thrasher, M. Laird Forrest and Li B . Nanomicellar TGX221 blocks xenograft tumor growth of prostate cancer in nude mice. The Prostate 2015 Jan 25. 75(6):593-602. PMID: 25620467.
  16. Liu WJ, Xu BH, Ye L, Liang D, Wu HL, Zheng YY, Deng JK, Li B , Liu HF. Urinary proteins induce lysosomal membrane permeabilization and lysosomal dysfunction in renal tubular epithelial cells. Am J Physiol Renal Physiol. 2015 Jan 13:ajprenal.00383.2014. doi: 10.1152/ajprenal.00383. 2014. PMID: 25587119.
  17. Li B , Sun A, Jiang W, Thrasher JB, Terranova. PI-3 kinase p110b: a therapeutic target in advanced prostate cancer. Am J Clin Exp Urol 2014, 2(3)188-198. PMID: 25374921.
  18. Chunjing Liu, Li B and Lester Mitscher. Synthesis of New TGX-221 Analogs. Naturforsch . 2014, 69b, 817–822. doi:10.5560/ZNB.2014-4081.
  19. Tang Y, Chen R, Huang Y, Li G, Huang Y, Chen J, Duan L, Zhu BT, Thrasher JB, Zhang X, Li B . Natural compound Alternol induces oxidative stress-dependent apoptotic cell death preferentially in prostate cancer cells. Mol Cancer Ther . 2014 Jun; 13(6):1526-36. PMID: 24688053.
  20. Liu WJ, Luo MN, Tan J, Chen W, Huang LZ, Yang C, Pan Q, Li B , Liu HF. Autophagy activation reduces renal tubular injury induced by urinary proteins. Autophagy . 2014; 10(2):243-56. doi: 10.4161/auto. 27004. PMID: 24345797.
  21. Luo HQ, Kuang XX and Li B . Updated roles of adrenergic receptors in prostate cancer. Zhonghua Nan Ke Xue . 2014 Apr; 20(4):372-6. Review in Chinese. PMID: 24873168.

Last modified: Feb 18, 2021
ID=x7279